Literature DB >> 4209883

Synthesis of von Willebrand factor by cultured human endothelial cells.

E A Jaffe, L W Hoyer, R L Nachman.   

Abstract

Cultured human endothelial cells synthesize and secrete a protein(s) which has Factor VIII antigen but which lacks Factor VIII clot-promoting activity (J. Clin. Invest. 52, 2757-2764, 1973). Von Willebrand factor activity has been identified in medium from cultured human endothelial cells. This activity was demonstrated by the ability to correct the defect in platelet adhesiveness of blood obtained from patients with von Willebrand's disease. This activity also supported ristocetin-induced aggregation of washed normal human platelets. The von Willebrand factor activity from cultured endothelial cells has physicochemical and immunologic properties like those of the von Willebrand factor activity and the Factor VIII antigen present in human plasma and the Factor VIII antigen synthesized by human endothelial cells in vitro. Rabbit antibody to chromatographic fractions containing endothelial cell von Willebrand factor inhibits the platelet retention of normal blood in glass bead columns.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4209883      PMCID: PMC388351          DOI: 10.1073/pnas.71.5.1906

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Antigen-biological-activity ratio for factor VIII.

Authors:  C Hougie; R Sargeant
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

2.  Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.

Authors:  B N Bouma; Y Wiegerinck; J J Sixma; J A Van Mourik; I A Mochtar
Journal:  Nat New Biol       Date:  1972-03-29

3.  Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate.

Authors:  H J Weiss; J Rogers
Journal:  Am J Med       Date:  1972-12       Impact factor: 4.965

4.  Iodination of the human platelet membrane. Studies of the major surface glycoprotein.

Authors:  R L Nachman; A Hubbard; B Ferris
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

5.  The isolation nd characterization of bovine factor VIII (antihemophilic factor).

Authors:  G Schmer; E P Kirby; D C Teller; E W Davie
Journal:  J Biol Chem       Date:  1972-04-25       Impact factor: 5.157

6.  Ristocetin--a new tool in the investigation of platelet aggregation.

Authors:  M A Howard; B G Firkin
Journal:  Thromb Diath Haemorrh       Date:  1971-10-31

7.  Platelet adhesiveness in von Willebrand's disease.

Authors:  E J Bowie; C A Owen; J H Thompson; P Didisheim
Journal:  Am J Clin Pathol       Date:  1969-07       Impact factor: 2.493

8.  Ultrastructural basis of experimental thrombocytopenic purpura.

Authors:  I Gore; M Takada; J Austin
Journal:  Arch Pathol       Date:  1970-09

9.  Reversible decrease in platelet retention by glass bead columns (adhesiveness) induced by disturbing the blood.

Authors:  B S Coller; M B Zucker
Journal:  Proc Soc Exp Biol Med       Date:  1971-03

10.  Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen.

Authors:  L W Hoyer
Journal:  J Lab Clin Med       Date:  1972-12
View more
  96 in total

1.  The effects of epinephrine infusion in patients with von Willebrand's disease.

Authors:  F R Rickles; L W Hoyer; M E Rick; D J Ahr
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

2.  Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells.

Authors:  E A Jaffe; R L Nachman
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

3.  Correction of a murine model of von Willebrand disease by gene transfer.

Authors:  Robert G Pergolizzi; Guangchun Jin; Diane Chan; Lorraine Pierre; James Bussel; Barbara Ferris; Philip L Leopold; Ronald G Crystal
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

4.  Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.

Authors:  D J Loskutoff; T E Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

5.  Effect of ephrin-A1/EphA2 on invasion of trophoblastic cells.

Authors:  Yun Yang; Jie Min
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

6.  Von Willebrand factor is reversibly decreased during torpor in 13-lined ground squirrels.

Authors:  Scott Cooper; Shawn Sell; Luke Nelson; Jennifer Hawes; Jacob A Benrud; Bridget M Kohlnhofer; Bradley R Burmeister; Veronica H Flood
Journal:  J Comp Physiol B       Date:  2016-01       Impact factor: 2.200

7.  Do current bladder smooth muscle cell isolation procedures result in a homogeneous cell population? Implications for bladder tissue engineering.

Authors:  Arun K Sharma; Jena L Donovan; Jennifer A Hagerty; Ryan R Sullivan; Seby L Edassery; Daniel A Harrington; Earl Y Cheng
Journal:  World J Urol       Date:  2009-02-21       Impact factor: 4.226

8.  Rickettsial interactions with human endothelial cells in vitro: adherence and entry.

Authors:  T S Walker
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

9.  Pseudomonas aeruginosa selective adherence to and entry into human endothelial cells.

Authors:  M C Plotkowski; A M Saliba; S H Pereira; M P Cervante; O Bajolet-Laudinat
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 10.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.